サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1123529

世界の風疹診断検査市場：考察と予測 (2028年まで)

Global Rubella Diagnostic Testing Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 119 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の風疹診断検査市場：考察と予測 (2028年まで)
出版日: 2022年09月08日
発行: QYResearch
ページ情報: 英文 119 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、風疹診断検査 (Rubella Diagnostic Testing) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の風疹診断検査の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Flow Cytometry
    • Latex Slide Agglutination Test
    • Monoclonal Antibodies
    • Immunoassays
    • Serological Testing
    • Clinical Evaluation
  • 市場：アプリケーション別
    • 世界の風疹診断検査の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Hospitals
    • Commercial
    • Physician Offices
    • Public Health Labs
    • Other
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の風疹診断検査の市場展望 (2017-2028)
  • 風疹診断検査の市場成長トレンド：地域別
    • 風疹診断検査 市場規模：地域別: 2017 VS 2021 VS 2028
    • 風疹診断検査の市場規模実績：地域別 (2017-2022)
    • 風疹診断検査の市場規模予測：地域別 (2023-2028)
  • 風疹診断検査 市場動向
    • 風疹診断検査 業界動向
    • 風疹診断検査 市場の促進要因
    • 風疹診断検査 市場の課題
    • 風疹診断検査 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の風疹診断検査の上位企業：収益別
    • 世界の風疹診断検査の上位企業：収益別 (2017-2022)
    • 世界の風疹診断検査の収益シェア：企業別 (2017-2022)
  • 世界の風疹診断検査の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：風疹診断検査の収益
  • 世界の風疹診断検査 市場集中度
    • 世界の風疹診断検査 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 風疹診断検査の収益 2021
  • 風疹診断検査の主要企業の本社および事業エリア
  • 主要企業 風疹診断検査の製品ソリューションおよびサービス
  • 市場参入時期： 風疹診断検査 市場
  • M&A, 拡張計画

第4章 風疹診断検査 内訳データ：タイプ別

  • 世界の風疹診断検査の市場規模実績：タイプ別 (2017-2022)
  • 世界の風疹診断検査の市場規模予測：タイプ別 (2023-2028)

第5章 風疹診断検査 内訳データ：アプリケーション別

  • 世界の風疹診断検査の市場規模実績：アプリケーション別 (2017-2022)
  • 世界の風疹診断検査の市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の風疹診断検査 市場規模 (2017-2028)
  • 北米の風疹診断検査 市場規模：タイプ別
    • 北米の風疹診断検査 市場規模：タイプ別 (2017-2022)
    • 北米の風疹診断検査 市場規模：タイプ別 (2023-2028)
    • 北米の風疹診断検査の市場シェア：タイプ別 (2017-2028)
  • 北米の風疹診断検査 市場規模：アプリケーション別
    • 北米の風疹診断検査 市場規模：アプリケーション別 (2017-2022)
    • 北米の風疹診断検査 市場規模：アプリケーション別 (2023-2028)
    • 北米の風疹診断検査の市場シェア：アプリケーション別 (2017-2028)
  • 北米の風疹診断検査 市場規模：国別
    • 北米の風疹診断検査 市場規模：国別 (2017-2022)
    • 北米の風疹診断検査 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の風疹診断検査 市場規模 (2017-2028)
  • 欧州の風疹診断検査 市場規模：タイプ別
    • 欧州の風疹診断検査 市場規模：タイプ別 (2017-2022)
    • 欧州の風疹診断検査 市場規模：タイプ別 (2023-2028)
    • 欧州の風疹診断検査の市場シェア：タイプ別 (2017-2028)
  • 欧州の風疹診断検査 市場規模：アプリケーション別
    • 欧州の風疹診断検査 市場規模：アプリケーション別 (2017-2022)
    • 欧州の風疹診断検査 市場規模：アプリケーション別 (2023-2028)
    • 欧州の風疹診断検査の市場シェア：アプリケーション別 (2017-2028)
  • 欧州の風疹診断検査 市場規模：国別
    • 欧州の風疹診断検査 市場規模：国別 (2017-2022)
    • 欧州の風疹診断検査 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 風疹診断検査 市場規模 (2017-2028)
  • アジア太平洋地域 風疹診断検査 市場規模：タイプ別
    • アジア太平洋地域 風疹診断検査 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 風疹診断検査 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 風疹診断検査の市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 風疹診断検査 市場規模：アプリケーション別
    • アジア太平洋地域 風疹診断検査 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 風疹診断検査 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 風疹診断検査の市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 風疹診断検査 市場規模：地域別
    • アジア太平洋地域 風疹診断検査 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 風疹診断検査 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの風疹診断検査 市場規模 (2017-2028)
  • ラテンアメリカの風疹診断検査 市場規模：タイプ別
    • ラテンアメリカの風疹診断検査 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカの風疹診断検査 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカの風疹診断検査の市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカの風疹診断検査 市場規模：アプリケーション別
    • ラテンアメリカの風疹診断検査 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカの風疹診断検査 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカの風疹診断検査の市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカの風疹診断検査 市場規模：国別
    • ラテンアメリカの風疹診断検査 市場規模：国別 (2017-2022)
    • ラテンアメリカの風疹診断検査 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの風疹診断検査 市場規模 (2017-2028)
  • 中東・アフリカの風疹診断検査 市場規模：タイプ別
    • 中東・アフリカの風疹診断検査 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカの風疹診断検査 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカの風疹診断検査の市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカの風疹診断検査 市場規模：アプリケーション別
    • 中東・アフリカの風疹診断検査 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカの風疹診断検査 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカの風疹診断検査の市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカの風疹診断検査 市場規模：国別
    • 中東・アフリカの風疹診断検査 市場規模：国別 (2017-2022)
    • 中東・アフリカの風疹診断検査 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Abbott Laboratories
  • Beckman Coulter
  • Bio Rad Laboratories
  • Biogate Laboratories
  • BioMerieux SA
  • Cigna
  • Diagnostic Laboratory of Oklahoma
  • GlaxoSmithKline
  • HealthLink BC
  • Mayo Clinic
  • Ortho Clinical Diagnostics
  • True Health

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Rubella Diagnostic Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Flow Cytometry
  • Table 3. Key Players of Latex Slide Agglutination Test
  • Table 4. Key Players of Monoclonal Antibodies
  • Table 5. Key Players of Immunoassays
  • Table 6. Key Players of Serological Testing
  • Table 7. Key Players of Clinical Evaluation
  • Table 8. Global Rubella Diagnostic Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 9. Global Rubella Diagnostic Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 10. Global Rubella Diagnostic Testing Market Size by Region (2017-2022) & (US$ Million)
  • Table 11. Global Rubella Diagnostic Testing Market Share by Region (2017-2022)
  • Table 12. Global Rubella Diagnostic Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 13. Global Rubella Diagnostic Testing Market Share by Region (2023-2028)
  • Table 14. Rubella Diagnostic Testing Market Trends
  • Table 15. Rubella Diagnostic Testing Market Drivers
  • Table 16. Rubella Diagnostic Testing Market Challenges
  • Table 17. Rubella Diagnostic Testing Market Restraints
  • Table 18. Global Rubella Diagnostic Testing Revenue by Players (2017-2022) & (US$ Million)
  • Table 19. Global Rubella Diagnostic Testing Revenue Share by Players (2017-2022)
  • Table 20. Global Top Rubella Diagnostic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rubella Diagnostic Testing as of 2021)
  • Table 21. Ranking of Global Top Rubella Diagnostic Testing Companies by Revenue (US$ Million) in 2021
  • Table 22. Global 5 Largest Players Market Share by Rubella Diagnostic Testing Revenue (CR5 and HHI) & (2017-2022)
  • Table 23. Key Players Headquarters and Area Served
  • Table 24. Key Players Rubella Diagnostic Testing Product Solution and Service
  • Table 25. Date of Enter into Rubella Diagnostic Testing Market
  • Table 26. Mergers & Acquisitions, Expansion Plans
  • Table 27. Global Rubella Diagnostic Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 28. Global Rubella Diagnostic Testing Revenue Market Share by Type (2017-2022)
  • Table 29. Global Rubella Diagnostic Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 30. Global Rubella Diagnostic Testing Revenue Market Share by Type (2023-2028)
  • Table 31. Global Rubella Diagnostic Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 32. Global Rubella Diagnostic Testing Revenue Share by Application (2017-2022)
  • Table 33. Global Rubella Diagnostic Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 34. Global Rubella Diagnostic Testing Revenue Share by Application (2023-2028)
  • Table 35. North America Rubella Diagnostic Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 36. North America Rubella Diagnostic Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 37. North America Rubella Diagnostic Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 38. North America Rubella Diagnostic Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 39. North America Rubella Diagnostic Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 40. North America Rubella Diagnostic Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 41. Europe Rubella Diagnostic Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 42. Europe Rubella Diagnostic Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 43. Europe Rubella Diagnostic Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 44. Europe Rubella Diagnostic Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 45. Europe Rubella Diagnostic Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 46. Europe Rubella Diagnostic Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Rubella Diagnostic Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Rubella Diagnostic Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 49. Asia Pacific Rubella Diagnostic Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 50. Asia Pacific Rubella Diagnostic Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 51. Asia Pacific Rubella Diagnostic Testing Market Size by Region (2017-2022) & (US$ Million)
  • Table 52. Asia Pacific Rubella Diagnostic Testing Market Size by Region (2023-2028) & (US$ Million)
  • Table 53. Latin America Rubella Diagnostic Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 54. Latin America Rubella Diagnostic Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 55. Latin America Rubella Diagnostic Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 56. Latin America Rubella Diagnostic Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 57. Latin America Rubella Diagnostic Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 58. Latin America Rubella Diagnostic Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Rubella Diagnostic Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Rubella Diagnostic Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 61. Middle East and Africa Rubella Diagnostic Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 62. Middle East and Africa Rubella Diagnostic Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 63. Middle East and Africa Rubella Diagnostic Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 64. Middle East and Africa Rubella Diagnostic Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 65. Abbott Laboratories Company Details
  • Table 66. Abbott Laboratories Business Overview
  • Table 67. Abbott Laboratories Rubella Diagnostic Testing Product
  • Table 68. Abbott Laboratories Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
  • Table 69. Abbott Laboratories Recent Developments
  • Table 70. Beckman Coulter Company Details
  • Table 71. Beckman Coulter Business Overview
  • Table 72. Beckman Coulter Rubella Diagnostic Testing Product
  • Table 73. Beckman Coulter Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
  • Table 74. Beckman Coulter Recent Developments
  • Table 75. Bio Rad Laboratories Company Details
  • Table 76. Bio Rad Laboratories Business Overview
  • Table 77. Bio Rad Laboratories Rubella Diagnostic Testing Product
  • Table 78. Bio Rad Laboratories Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
  • Table 79. Bio Rad Laboratories Recent Developments
  • Table 80. Biogate Laboratories Company Details
  • Table 81. Biogate Laboratories Business Overview
  • Table 82. Biogate Laboratories Rubella Diagnostic Testing Product
  • Table 83. Biogate Laboratories Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
  • Table 84. Biogate Laboratories Recent Developments
  • Table 85. BioMerieux SA Company Details
  • Table 86. BioMerieux SA Business Overview
  • Table 87. BioMerieux SA Rubella Diagnostic Testing Product
  • Table 88. BioMerieux SA Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
  • Table 89. BioMerieux SA Recent Developments
  • Table 90. Cigna Company Details
  • Table 91. Cigna Business Overview
  • Table 92. Cigna Rubella Diagnostic Testing Product
  • Table 93. Cigna Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
  • Table 94. Cigna Recent Developments
  • Table 95. Diagnostic Laboratory of Oklahoma Company Details
  • Table 96. Diagnostic Laboratory of Oklahoma Business Overview
  • Table 97. Diagnostic Laboratory of Oklahoma Rubella Diagnostic Testing Product
  • Table 98. Diagnostic Laboratory of Oklahoma Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
  • Table 99. Diagnostic Laboratory of Oklahoma Recent Developments
  • Table 100. GlaxoSmithKline Company Details
  • Table 101. GlaxoSmithKline Business Overview
  • Table 102. GlaxoSmithKline Rubella Diagnostic Testing Product
  • Table 103. GlaxoSmithKline Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
  • Table 104. GlaxoSmithKline Recent Developments
  • Table 105. HealthLink BC Company Details
  • Table 106. HealthLink BC Business Overview
  • Table 107. HealthLink BC Rubella Diagnostic Testing Product
  • Table 108. HealthLink BC Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
  • Table 109. HealthLink BC Recent Developments
  • Table 110. Mayo Clinic Company Details
  • Table 111. Mayo Clinic Business Overview
  • Table 112. Mayo Clinic Rubella Diagnostic Testing Product
  • Table 113. Mayo Clinic Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
  • Table 114. Mayo Clinic Recent Developments
  • Table 115. Ortho Clinical Diagnostics Company Details
  • Table 116. Ortho Clinical Diagnostics Business Overview
  • Table 117. Ortho Clinical Diagnostics Rubella Diagnostic Testing Product
  • Table 118. Ortho Clinical Diagnostics Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
  • Table 119. Ortho Clinical Diagnostics Recent Developments
  • Table 120. True Health Company Details
  • Table 121. True Health Business Overview
  • Table 122. True Health Rubella Diagnostic Testing Product
  • Table 123. True Health Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
  • Table 124. True Health Recent Developments
  • Table 125. Research Programs/Design for This Report
  • Table 126. Key Data Information from Secondary Sources
  • Table 127. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Rubella Diagnostic Testing Market Share by Type: 2021 VS 2028
  • Figure 2. Flow Cytometry Features
  • Figure 3. Latex Slide Agglutination Test Features
  • Figure 4. Monoclonal Antibodies Features
  • Figure 5. Immunoassays Features
  • Figure 6. Serological Testing Features
  • Figure 7. Clinical Evaluation Features
  • Figure 8. Global Rubella Diagnostic Testing Market Share by Application: 2021 VS 2028
  • Figure 9. Hospitals Case Studies
  • Figure 10. Commercial Case Studies
  • Figure 11. Physician Offices Case Studies
  • Figure 12. Public Health Labs Case Studies
  • Figure 13. Other Case Studies
  • Figure 14. Rubella Diagnostic Testing Report Years Considered
  • Figure 15. Global Rubella Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 16. Global Rubella Diagnostic Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 17. Global Rubella Diagnostic Testing Market Share by Region: 2021 VS 2028
  • Figure 18. Global Rubella Diagnostic Testing Market Share by Players in 2021
  • Figure 19. Global Top Rubella Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rubella Diagnostic Testing as of 2021)
  • Figure 20. The Top 10 and 5 Players Market Share by Rubella Diagnostic Testing Revenue in 2021
  • Figure 21. North America Rubella Diagnostic Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 22. North America Rubella Diagnostic Testing Market Size Market Share by Type (2017-2028)
  • Figure 23. North America Rubella Diagnostic Testing Market Size Market Share by Application (2017-2028)
  • Figure 24. North America Rubella Diagnostic Testing Market Size Share by Country (2017-2028)
  • Figure 25. United States Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 26. Canada Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. Europe Rubella Diagnostic Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 28. Europe Rubella Diagnostic Testing Market Size Market Share by Type (2017-2028)
  • Figure 29. Europe Rubella Diagnostic Testing Market Size Market Share by Application (2017-2028)
  • Figure 30. Europe Rubella Diagnostic Testing Market Size Share by Country (2017-2028)
  • Figure 31. Germany Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. France Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. U.K. Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 34. Italy Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 35. Russia Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 36. Nordic Countries Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. Asia-Pacific Rubella Diagnostic Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 38. Asia Pacific Rubella Diagnostic Testing Market Size Market Share by Type (2017-2028)
  • Figure 39. Asia Pacific Rubella Diagnostic Testing Market Size Market Share by Application (2017-2028)
  • Figure 40. Asia Pacific Rubella Diagnostic Testing Market Size Share by Region (2017-2028)
  • Figure 41. China Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. Japan Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. South Korea Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 44. Southeast Asia Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 45. India Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 46. Australia Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 47. Latin America Rubella Diagnostic Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 48. Latin America Rubella Diagnostic Testing Market Size Market Share by Type (2017-2028)
  • Figure 49. Latin America Rubella Diagnostic Testing Market Size Market Share by Application (2017-2028)
  • Figure 50. Latin America Rubella Diagnostic Testing Market Size Share by Country (2017-2028)
  • Figure 51. Mexico Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 52. Brazil Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. Middle East & Africa Rubella Diagnostic Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 54. Middle East and Africa Rubella Diagnostic Testing Market Size Market Share by Type (2017-2028)
  • Figure 55. Middle East and Africa Rubella Diagnostic Testing Market Size Market Share by Application (2017-2028)
  • Figure 56. Middle East and Africa Rubella Diagnostic Testing Market Size Share by Country (2017-2028)
  • Figure 57. Turkey Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 58. Saudi Arabia Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 59. UAE Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 60. Abbott Laboratories Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
  • Figure 61. Beckman Coulter Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
  • Figure 62. Bio Rad Laboratories Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
  • Figure 63. Biogate Laboratories Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
  • Figure 64. BioMerieux SA Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
  • Figure 65. Cigna Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
  • Figure 66. Diagnostic Laboratory of Oklahoma Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
  • Figure 67. GlaxoSmithKline Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
  • Figure 68. HealthLink BC Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
  • Figure 69. Mayo Clinic Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
  • Figure 70. Ortho Clinical Diagnostics Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
  • Figure 71. True Health Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
  • Figure 72. Bottom-up and Top-down Approaches for This Report
  • Figure 73. Data Triangulation
  • Figure 74. Key Executives Interviewed
目次

This research report focuses on the Rubella Diagnostic Testing Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Rubella Diagnostic Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Flow Cytometry
    • 1.2.3 Latex Slide Agglutination Test
    • 1.2.4 Monoclonal Antibodies
    • 1.2.5 Immunoassays
    • 1.2.6 Serological Testing
    • 1.2.7 Clinical Evaluation
  • 1.3 Market by Application
    • 1.3.1 Global Rubella Diagnostic Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospitals
    • 1.3.3 Commercial
    • 1.3.4 Physician Offices
    • 1.3.5 Public Health Labs
    • 1.3.6 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Rubella Diagnostic Testing Market Perspective (2017-2028)
  • 2.2 Rubella Diagnostic Testing Growth Trends by Region
    • 2.2.1 Rubella Diagnostic Testing Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Rubella Diagnostic Testing Historic Market Size by Region (2017-2022)
    • 2.2.3 Rubella Diagnostic Testing Forecasted Market Size by Region (2023-2028)
  • 2.3 Rubella Diagnostic Testing Market Dynamics
    • 2.3.1 Rubella Diagnostic Testing Industry Trends
    • 2.3.2 Rubella Diagnostic Testing Market Drivers
    • 2.3.3 Rubella Diagnostic Testing Market Challenges
    • 2.3.4 Rubella Diagnostic Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Rubella Diagnostic Testing Players by Revenue
    • 3.1.1 Global Top Rubella Diagnostic Testing Players by Revenue (2017-2022)
    • 3.1.2 Global Rubella Diagnostic Testing Revenue Market Share by Players (2017-2022)
  • 3.2 Global Rubella Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Rubella Diagnostic Testing Revenue
  • 3.4 Global Rubella Diagnostic Testing Market Concentration Ratio
    • 3.4.1 Global Rubella Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Rubella Diagnostic Testing Revenue in 2021
  • 3.5 Rubella Diagnostic Testing Key Players Head office and Area Served
  • 3.6 Key Players Rubella Diagnostic Testing Product Solution and Service
  • 3.7 Date of Enter into Rubella Diagnostic Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Rubella Diagnostic Testing Breakdown Data by Type

  • 4.1 Global Rubella Diagnostic Testing Historic Market Size by Type (2017-2022)
  • 4.2 Global Rubella Diagnostic Testing Forecasted Market Size by Type (2023-2028)

5 Rubella Diagnostic Testing Breakdown Data by Application

  • 5.1 Global Rubella Diagnostic Testing Historic Market Size by Application (2017-2022)
  • 5.2 Global Rubella Diagnostic Testing Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Rubella Diagnostic Testing Market Size (2017-2028)
  • 6.2 North America Rubella Diagnostic Testing Market Size by Type
    • 6.2.1 North America Rubella Diagnostic Testing Market Size by Type (2017-2022)
    • 6.2.2 North America Rubella Diagnostic Testing Market Size by Type (2023-2028)
    • 6.2.3 North America Rubella Diagnostic Testing Market Share by Type (2017-2028)
  • 6.3 North America Rubella Diagnostic Testing Market Size by Application
    • 6.3.1 North America Rubella Diagnostic Testing Market Size by Application (2017-2022)
    • 6.3.2 North America Rubella Diagnostic Testing Market Size by Application (2023-2028)
    • 6.3.3 North America Rubella Diagnostic Testing Market Share by Application (2017-2028)
  • 6.4 North America Rubella Diagnostic Testing Market Size by Country
    • 6.4.1 North America Rubella Diagnostic Testing Market Size by Country (2017-2022)
    • 6.4.2 North America Rubella Diagnostic Testing Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Rubella Diagnostic Testing Market Size (2017-2028)
  • 7.2 Europe Rubella Diagnostic Testing Market Size by Type
    • 7.2.1 Europe Rubella Diagnostic Testing Market Size by Type (2017-2022)
    • 7.2.2 Europe Rubella Diagnostic Testing Market Size by Type (2023-2028)
    • 7.2.3 Europe Rubella Diagnostic Testing Market Share by Type (2017-2028)
  • 7.3 Europe Rubella Diagnostic Testing Market Size by Application
    • 7.3.1 Europe Rubella Diagnostic Testing Market Size by Application (2017-2022)
    • 7.3.2 Europe Rubella Diagnostic Testing Market Size by Application (2023-2028)
    • 7.3.3 Europe Rubella Diagnostic Testing Market Share by Application (2017-2028)
  • 7.4 Europe Rubella Diagnostic Testing Market Size by Country
    • 7.4.1 Europe Rubella Diagnostic Testing Market Size by Country (2017-2022)
    • 7.4.2 Europe Rubella Diagnostic Testing Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Rubella Diagnostic Testing Market Size (2017-2028)
  • 8.2 Asia-Pacific Rubella Diagnostic Testing Market Size by Type
    • 8.2.1 Asia-Pacific Rubella Diagnostic Testing Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Rubella Diagnostic Testing Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Rubella Diagnostic Testing Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Rubella Diagnostic Testing Market Size by Application
    • 8.3.1 Asia-Pacific Rubella Diagnostic Testing Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Rubella Diagnostic Testing Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Rubella Diagnostic Testing Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Rubella Diagnostic Testing Market Size by Region
    • 8.4.1 Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Rubella Diagnostic Testing Market Size (2017-2028)
  • 9.2 Latin America Rubella Diagnostic Testing Market Size by Type
    • 9.2.1 Latin America Rubella Diagnostic Testing Market Size by Type (2017-2022)
    • 9.2.2 Latin America Rubella Diagnostic Testing Market Size by Type (2023-2028)
    • 9.2.3 Latin America Rubella Diagnostic Testing Market Share by Type (2017-2028)
  • 9.3 Latin America Rubella Diagnostic Testing Market Size by Application
    • 9.3.1 Latin America Rubella Diagnostic Testing Market Size by Application (2017-2022)
    • 9.3.2 Latin America Rubella Diagnostic Testing Market Size by Application (2023-2028)
    • 9.3.3 Latin America Rubella Diagnostic Testing Market Share by Application (2017-2028)
  • 9.4 Latin America Rubella Diagnostic Testing Market Size by Country
    • 9.4.1 Latin America Rubella Diagnostic Testing Market Size by Country (2017-2022)
    • 9.4.2 Latin America Rubella Diagnostic Testing Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Rubella Diagnostic Testing Market Size (2017-2028)
  • 10.2 Middle East & Africa Rubella Diagnostic Testing Market Size by Type
    • 10.2.1 Middle East & Africa Rubella Diagnostic Testing Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Rubella Diagnostic Testing Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Rubella Diagnostic Testing Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Rubella Diagnostic Testing Market Size by Application
    • 10.3.1 Middle East & Africa Rubella Diagnostic Testing Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Rubella Diagnostic Testing Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Rubella Diagnostic Testing Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Rubella Diagnostic Testing Market Size by Country
    • 10.4.1 Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview
    • 11.1.3 Abbott Laboratories Rubella Diagnostic Testing Introduction
    • 11.1.4 Abbott Laboratories Revenue in Rubella Diagnostic Testing Business (2017-2022)
    • 11.1.5 Abbott Laboratories Recent Developments
  • 11.2 Beckman Coulter
    • 11.2.1 Beckman Coulter Company Details
    • 11.2.2 Beckman Coulter Business Overview
    • 11.2.3 Beckman Coulter Rubella Diagnostic Testing Introduction
    • 11.2.4 Beckman Coulter Revenue in Rubella Diagnostic Testing Business (2017-2022)
    • 11.2.5 Beckman Coulter Recent Developments
  • 11.3 Bio Rad Laboratories
    • 11.3.1 Bio Rad Laboratories Company Details
    • 11.3.2 Bio Rad Laboratories Business Overview
    • 11.3.3 Bio Rad Laboratories Rubella Diagnostic Testing Introduction
    • 11.3.4 Bio Rad Laboratories Revenue in Rubella Diagnostic Testing Business (2017-2022)
    • 11.3.5 Bio Rad Laboratories Recent Developments
  • 11.4 Biogate Laboratories
    • 11.4.1 Biogate Laboratories Company Details
    • 11.4.2 Biogate Laboratories Business Overview
    • 11.4.3 Biogate Laboratories Rubella Diagnostic Testing Introduction
    • 11.4.4 Biogate Laboratories Revenue in Rubella Diagnostic Testing Business (2017-2022)
    • 11.4.5 Biogate Laboratories Recent Developments
  • 11.5 BioMerieux SA
    • 11.5.1 BioMerieux SA Company Details
    • 11.5.2 BioMerieux SA Business Overview
    • 11.5.3 BioMerieux SA Rubella Diagnostic Testing Introduction
    • 11.5.4 BioMerieux SA Revenue in Rubella Diagnostic Testing Business (2017-2022)
    • 11.5.5 BioMerieux SA Recent Developments
  • 11.6 Cigna
    • 11.6.1 Cigna Company Details
    • 11.6.2 Cigna Business Overview
    • 11.6.3 Cigna Rubella Diagnostic Testing Introduction
    • 11.6.4 Cigna Revenue in Rubella Diagnostic Testing Business (2017-2022)
    • 11.6.5 Cigna Recent Developments
  • 11.7 Diagnostic Laboratory of Oklahoma
    • 11.7.1 Diagnostic Laboratory of Oklahoma Company Details
    • 11.7.2 Diagnostic Laboratory of Oklahoma Business Overview
    • 11.7.3 Diagnostic Laboratory of Oklahoma Rubella Diagnostic Testing Introduction
    • 11.7.4 Diagnostic Laboratory of Oklahoma Revenue in Rubella Diagnostic Testing Business (2017-2022)
    • 11.7.5 Diagnostic Laboratory of Oklahoma Recent Developments
  • 11.8 GlaxoSmithKline
    • 11.8.1 GlaxoSmithKline Company Details
    • 11.8.2 GlaxoSmithKline Business Overview
    • 11.8.3 GlaxoSmithKline Rubella Diagnostic Testing Introduction
    • 11.8.4 GlaxoSmithKline Revenue in Rubella Diagnostic Testing Business (2017-2022)
    • 11.8.5 GlaxoSmithKline Recent Developments
  • 11.9 HealthLink BC
    • 11.9.1 HealthLink BC Company Details
    • 11.9.2 HealthLink BC Business Overview
    • 11.9.3 HealthLink BC Rubella Diagnostic Testing Introduction
    • 11.9.4 HealthLink BC Revenue in Rubella Diagnostic Testing Business (2017-2022)
    • 11.9.5 HealthLink BC Recent Developments
  • 11.10 Mayo Clinic
    • 11.10.1 Mayo Clinic Company Details
    • 11.10.2 Mayo Clinic Business Overview
    • 11.10.3 Mayo Clinic Rubella Diagnostic Testing Introduction
    • 11.10.4 Mayo Clinic Revenue in Rubella Diagnostic Testing Business (2017-2022)
    • 11.10.5 Mayo Clinic Recent Developments
  • 11.11 Ortho Clinical Diagnostics
    • 11.11.1 Ortho Clinical Diagnostics Company Details
    • 11.11.2 Ortho Clinical Diagnostics Business Overview
    • 11.11.3 Ortho Clinical Diagnostics Rubella Diagnostic Testing Introduction
    • 11.11.4 Ortho Clinical Diagnostics Revenue in Rubella Diagnostic Testing Business (2017-2022)
    • 11.11.5 Ortho Clinical Diagnostics Recent Developments
  • 11.12 True Health
    • 11.12.1 True Health Company Details
    • 11.12.2 True Health Business Overview
    • 11.12.3 True Health Rubella Diagnostic Testing Introduction
    • 11.12.4 True Health Revenue in Rubella Diagnostic Testing Business (2017-2022)
    • 11.12.5 True Health Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer